Scientists from Australia and the USA have developed a lymph node-targeted multi-epitope subunit vaccine that induces strong humoral and cellular immune responses against Epstein-Barr virus (EBV) in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results